NCT00438984
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Recurrent Melanoma
Explore clinical trials studying Recurrent Melanoma. Study availability and eligibility vary by location and protocol.
83 public trials
2 recruiting studies
Recurrent Melanoma trial results
NCT00003646
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Physician Reliance Network, Inc. Dallas, Texas, United States
Completed
Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00003647
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas Encinitas, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group San Diego, California, United States
Active, Not Recruiting
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338
- Conditions
- Melanoma, Melanoma of Unknown Primary, Neoplasms, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Alaska Regional Hospital Anchorage, Alaska, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
NCT02298959
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
- Locations
-
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
Active, Not Recruiting
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
NCT02224781
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
NCT01134614
- Conditions
- Advanced Melanoma, Melanoma, Metastatic Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- VA Palo Alto Health Care System Palo Alto, California, United States
- Eisenhower Medical Center Rancho Mirage, California, United States
Active, Not Recruiting
Dinaciclib in Treating Patients With Stage IV Melanoma
NCT00937937
- Conditions
- Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma, +16 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Highlands Oncology Group - Rogers Rogers, Arkansas, United States